Sanofi agreed to pay Teva Pharmaceutical Industries Inc. as much as $1.5 billion to help develop and sell a medicine for inflammatory bowel disease, its second deal to gain a new experimental treatment this week.
In a social media landscape shaped by hashtags, algorithms, and viral posts, nurse leaders must decide: Will they let the narrative spiral, or can they adapt and join the conversation?
...
